Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gm.cd40l.ccl21 (1 trial)
gm.cd40l cells (1 trial)
Adenocarcinoma (Phase 2)
Lung Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)